[1] 赵家良,雎瑞芳,贾丽君,等.北京市顺义县50岁及以上人群中青光眼患病率和正常眼眼压的调查[J].中华眼科杂志,2002,38(6):335-339.
[2] He M,Foster P J,Ge J, et al.Prevalence and clinical characteristics of glaucoma in adult Chinese:a population-based study in Liwan District,Guangzhou[J].Invest Ophthalmol Vis Sci,2006,47(7):2782-2788.
[3] Park B C, Tibudan M, Samaraweera M. Interaction between two glaucoma genes, optineurin and myocilin[J]. Genes Cells, 2007,12(8):969-979.
[4] Gramer G, Weber B H, Gramer E. Results of a patient-directed survey on frequency of family history of glaucoma in 2170 patients[J].Invest Ophthalmol Vis Sci, 2014, 55(1): 259-264.
[5] Coleman A L, Miglior S. Risk factors for glaucoma onset and progression[J]. Surv Ophthalmol, 2008, 53(Supp1): S3-10.
[6] 董诗圆,姒怡冰,张宇燕,等.女性原发性开角型青光眼发病的危险因素分析[J].中华眼科杂志,2013,49(2):122-125.
[7] 马建州,贺翔鸽 . 免疫系统与青光眼 [J]. 国际眼科杂志,2007,8(5):1379-1383.
[8] Latina M A,Park C.Selective targeting of trabecular meshwork cells:in vitro studies of pulsed and CW laser interactions[J].Exper Eye Res,1995,60(4):359-371.
[9] 王 涛,王宁利.选择性激光小梁成形术治疗原发性开角型青光眼的一年疗效观察[J].眼科,2007,16(1):37-39.
[10] Kóthy P,Tóth M,Holló G.Influence of selective laser trabeculoplasty on 24-hour diurnal intraocular pressure fluctuation in primary open-angle glaucoma:a pilot study[J].Ophthalmic Surg Lasers Imaging,2010,41(3):342-347.
[11] Gracner T,Falez M,Gracner B,et al.Long-term follow-up of selective laser trabeculoplasty inprimary open-angle glaucoma[J].Klin Monbl Augenheitkd,2006,223(9):743-747.
[12] Babighian S, Caretti L, Tavolato M, et al . Excimer laser trabeculotomy vs 180 degrees selective laser trabeculoplasty in primary open- angle glaucoma. A 2 - year randomized, controlled trial[J]. Eye ( Lond ) ,2009,24(4):632-638.
[13] 葛 坚,孙兴怀,王宁利,等.现代青光眼研究进展[M]. 北京:科学出版社,2000:286-288.
[14] 许钦玉,杨玉峰,荣守亮.三角形和距形巩膜瓣下滤过术的疗效比较[J].华北煤炭医学院学报,2003,5(3):339.
[15] 王瑞夫,高晓唯,闫希冬,等.二次可调整缝线在小梁切除术中的临床观察 [J].国际眼科杂志,2007,7(3):821-822.
[16] 林瑞杰.巩膜瓣可调整缝线在小梁切除术中的临床观察 [J].国际眼科杂志,2006,6(1):194-195.
[17] De Barros D S,Gheith M E,Siam G A,et al.Releasable suture technique[J].J Glaucoma,2008,17(5):414-421.
[18] Lattanzio F A Jr,Crouch E R Jr,Mitrev P V,et al.Cyclosporin as all adjunct to glaucoma filtration surgery[J].J Glaucoma,2005,14(6):441-447.
[19] 廖海兰,阎亦农,魏建初.抗转化生长因子β₂抗体对青光眼术 后滤过泡成纤维细胞增殖及p2l、cyclinDl表达的影响[J].中国组织上程研究与临床康复,2008,12(28):5401-5405.
[20] 刘武装,寇 婷.改良复合式小梁切除术治疗青先眼的临床观察[J].国际眼科杂志,20ll,7(9):109-1l0.
[21] Molteno A C B.New implant for drainage in glaucoma:clinical trial[J]. Br J Ophthalmol,1969,53(9):606-615.
[22] Kiage D O,Gredin D,Giehuhi S,et al.Ahmed glaucoma valve implant:experience in Eest Africa[J].Middle Eest Air J Ophthalmol,2009,16(3):151-155.
[23] Kitazawa Y,Yamamoto T,Sawada A,et al.Surgery for refractory glaucoma[J].Aust New Zeal J Ophthalmol,1996,24(4):327-332.
[24] 孙 重,吴作红.Ahmed青光眼引流阀治疗新生血管性青光眼的临床疗效[J].国际眼科杂志,2014,14(2):243-245.
[25] 颜雪峰. 青光眼手术治疗的研究进展[J].中国实用眼科杂志,2015,33(3):227-230.
[26] De Jong L, Lafuma A, Aguadé A S,et al. Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma[J]. Clin Ophthalmol, 2010,5(1): 527-533.
[27] Francis B A, Singh K, Lin S C, et al . Novel glaucoma procedures: a report by the American Academy of Ophthalmology[J]. Ophthalmology ,2011,118(7):1466-1480.
[28] 陈霄雅,王怀洲,王宁利.微创青光眼手术新进展[J].眼科,2014,23(1):64-68.
[29] Craven E R, Katz L J, Wells J M. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: Two-year follow-up[J].Cataract Refract Surg,2012,38(8): 1339-1345.
[30] Helmut H, Ahmed I K, Swaantje G, et al. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery [J].Cataract Refract Surg, 2013, 39: 431-437.